| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |